Skip Navigation

   

Studies

List of Studies in the Chronic Kidney Disease Consortium - Phase 3

(Phase 1 Studies) (Phase 2 Studies)

Collaborators (study name + investigators)

African American Study of Kidney Disease and Hypertension (AASK): Jackson Wright, Lawrence Appel, Tom Greene, Brad C Astor

The Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial (ADVANCE): John Chalmers, Stephen MacMahon, Mark Woodward, Hisatomi Arima

Aichi Workers’ Cohort (Aichi): Hiroshi Yatsuya, Kentaro Yamashita, Hideaki Toyoshima, Koji Tamakoshi

Alberta Kidney Disease Network (AKDN): Marcello Tonelli, Brenda R Hemmelgarn, Matt James, Tanvir C Turin

Atherosclerosis Risk in Communities Study (ARIC): Josef Coresh, Brad C Astor, Kunihiro Matsushita, Morgan Grams, Yingying Sang

Australian Diabetes, Obesity, and Lifestyle Study (AusDiab): Robert C Atkins, Kevan R Polkinghorne, Steven Chadban

Beaver Dam CKD Study: Ronald Klein, Barbara EK Klein, Anoop Shankar, Kristine E Lee

British Columbia CKD Study (BC CKD): Adeera Levin, Ognjenka Djurdjev

The Cholesterol and Recurrent Events Trial (CARE): Marcello Tonelli, Frank M Sacks, Gary C Curhan

CARE FOR HOMe: Gunnar Heine, Adam M Zawada, Sarah Seiler, Insa Emrich, Lucie Bauer

Cardiovasular Health Study (CHS): Michael Shlipak, Mark Sarnak, Ronit Katz

Circulatory Risk in Communities Study (CIRCS): Hiroyasu Iso, Akihiko Kitamura, Tetsuya Ohira, Kazumasa Yamagishi

Cleveland Clinic (CCF): Sankar D Navaneethan, Joseph V Nally, Jesse D Schold

COBRA study: Tazeen H Jafar, Muhammad Islam, Juanita Hatcher, Neil Poulter, Nish Chaturvedi

Chronic Renal Impairment in Birmingham (CRIB): Martin J Landray, Jonathan R Emberson, John N Townend, David C Wheeler

ESTHER Study: Dietrich Rothenbacher, Hermann Brenner, Heiko Müller, Ben Schöttker

Framingham Heart Study (Framingham): Caroline S Fox; Shih-Jen Hwang, James B Meigs

Geisinger CKD Study: Jamie Green, H Lester Kirchner, Robert M Perkins, Alex R Chang

Grampian Laboratory Outcomes, Morbidity and Mortality Studies -1 (GLOMMS-1): Corri Black, Angharad Marks, Nick Fluck, Gordon J Prescott

Gubbio Study: Massimo Cirillo

Nord Trøndelag Health Study (HUNT): Stein Hallan, Knut Aasarød, Cecilia M Øien, Marie Radtke

Ibaraki Prefectual Health Study (IPHS): Fujiko Irie, Hiroyasu Iso, Toshimi Sairenchi, Kazumasa Yamagishi

Kaiser Permanente NW (KPNW): David H Smith, Eric S Johnson, Micah L Thorp

Kangbuk Samsung Heath Study (KSHS): Eliseo Guallar, Seungho Ryu, Yoosoo Chang, Juhee Cho, Hocheol Shin

Kidney Early Evaluation Program (KEEP): Allan J Collins, Joseph A Vassalotti, Suying Li, Shu-Cheng Chen

Kaiser Permanente Hawaii Cohort (KP Hawaii): Brian J Lee

Maccabi Health System (Maccabi): Gabriel Chodik, Varda Shalev, Yair C Birnbaum, Bracha Shainberg

Multifactorial Approach and Superior Treatment Efficacy in Renal Patients with the Aid of a Nurse Practitioner (MASTERPLAN): Jack F Wetzels, Peter J Blankestijn, Arjan D van Zuilen

Modification of Diet in Renal Disease Study (MDRD): Mark Sarnak, Andrew S Levey, Lesley Inker, Vandana Menon

Multi-Ethnic Study of Atherosclerosis (MESA): Michael Shlipak, Mark Sarnak, Carmen Peralta, Ronit Katz, Holly J Kramer, Ian H de Boer

Mild to Moderate Kidney Disease Study (MMKD): Florian Kronenberg, Barbara Kollerits, Eberhard Ritz

MRC Study of assessment of older people (MRC Older People): Paul Roderick, Dorothea Nitsch, Astrid Fletcher, Christopher Bulpitt

Multiple Risk Factor Intervention Trial (MRFIT): Areef Ishani, James D Neaton

NephroTest Study: Marc Froissart, Benedicte Stengel, Marie Metzger, Jean-Philippe Haymann, Pascal Houillier, Martin Flamant

New Zealand Diabetes Cohort Study (NZDCS): C Raina Elley, Timothy Kenealy, Simon A Moyes, John F Collins, Paul Drury

Third US National Health and Nutrition Examination Survey (NHANES III): Brad C Astor, Josef Coresh, Kunihiro Matsushita

Ohasama Study: Takayoshi Ohkubo, Hirohito Metoki, Masaaki Nakayama, Masahiro Kikuya, Yutaka Imai

Okinawa 83 and 93 Cohorts: Kunitoshi Iseki

Pima Indian: Robert G Nelson, William C Knowler

Prevention of Renal and Vascular End-stage Disease Study (PREVEND): Ron T Gansevoort, Paul E de Jong, Stephen JL Bakker, Hans L Hillege, Pim van der Harst

Rancho Bernardo Study: Simerjot Kaur Jassal, Elizabeth Barrett-Connor, Jaclyn Bergstrom

Reduction of Endpoints in Non-insulin Dependent Diabetes Mellitus with the Angiotensin II Antagonist Losartan (RENAAL): Hiddo J Lambers Heerspink, Barry E Brenner, Dick de Zeeuw

Reason for Geographic And Racial Differences in Stroke Study (REGARDS): David G Warnock, Paul Muntner, Suzanne Judd, William McClellan

Severance Cohort Study: Sun Ha Jee, Heejin Kimm, Jaeseong Jo, Yejin Mok, Eunmi Choi

Sunnybrook Cohort: Navdeep Tangri, David Naimark

Taiwan MJ Cohort Study (Taiwan): Chi-Pang Wen, Sung-Feng Wen, Chwen-Keng Tsao, Min-Kuang Tsai

Uppsala Longitudinal Study of Adult Men (ULSAM): Johan Ärnlöv, Lars Lannfelt, Anders Larsson

Veterans' Administration CKD Study (VA CKD): Csaba P Kovesdy, Kamyar Kalantar-Zadeh

Zwolle Outpatient Diabetes project Integrating Available Care (ZODIAC): Henk J Bilo, Hanneke Joosten, Nanno Kleefstra, Klaas H Groenier, Iefke Drion

 

© 2016, Johns Hopkins University. All rights reserved.
Web policies, 615 N. Wolfe Street, Baltimore, MD 21205